TY  - GEN
AU  - Gregori,Ninel Z
AU  - Gaitan,Jaime
AU  - Rosenfeld,Philip J
AU  - Puliafito,Carmen A
AU  - Feuer,William
AU  - Flynn,Harry W
AU  - Berrocal,Audina M
AU  - Al-Attar,Luma
AU  - Dubovy,Sander
AU  - Smiddy,William E
AU  - Schwartz,Stephen G
AU  - Lee,Wen-Hsiang
AU  - Murray,Timothy G
TI  - Long-term safety and efficacy of intravitreal bevacizumab (Avastin) for the management of central retinal vein occlusion
SN  - 1539-2864
PY  - 2009///0625
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal
KW  - administration & dosage
KW  - Antibodies, Monoclonal, Humanized
KW  - Bevacizumab
KW  - Female
KW  - Follow-Up Studies
KW  - Humans
KW  - Injections
KW  - Macula Lutea
KW  - drug effects
KW  - Macular Edema
KW  - diagnosis
KW  - Male
KW  - Middle Aged
KW  - Retinal Vein Occlusion
KW  - complications
KW  - Retrospective Studies
KW  - Time Factors
KW  - Tomography, Optical Coherence
KW  - Treatment Outcome
KW  - Vascular Endothelial Growth Factor A
KW  - antagonists & inhibitors
KW  - Visual Acuity
KW  - Vitreous Body
N1  - Publication Type: Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1097/IAE.0b013e318188501f
ER  -